A new study of more than 700,000 UK men finds that Black men with raised prostate-specific antigen (PSA) levels have the highest 1-year incidence of prostate cancer, whereas Asian men have the lowest ...
Routine PSA testing is not recommend by the USPSTF for men 70 and older, a group expected to derive little benefit. Similar to trends in the U.S., this U.K. study found that a high number of older men ...
Screening for prostate cancer is burdened by a high rate of overdiagnosis. The most appropriate algorithm for population-based screening is unknown. We invited 37,887 men who were 50 to 60 years of ...
As PSA testing recommendations change and the debate surrounding testing continues, people with a high-risk of prostate cancer and their families need to stay informed. John Salata says he is grateful ...
Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...
Prostate cancer is one of the most common cancers that occur in men. While it can be life-threatening, the disease is treatable, and the earlier it is detected, the better the treatment outcome.
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback